ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.

The NIH will not create an autism registry as part of its $50 million project to research autism spectrum disorder.

Pregnant patients with T2IDs using dupilumab did not have an increased rate of adverse events when compared with patients not receiving dupilumab.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Pertussis cases are increased this year vs 2024, potentially due in part to lower vaccination rates among children.

ACIP recommends pentavalent meningococcal vaccine Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) for individuals 10 through 25 years of age.

SSDI to the standard of care for melanoma screening among patients at high-risk increased the number of excisions performed.

The general fertility rate among women in the US increased slightly from 2023 to 2024, but it decreased among teens.

The Food and Drug Administration has granted Fast Track designation to bempikibart for the treatment of alopecia areata.

Pretrained foundation models for diagnosing nonmelanoma skin cancer outperformed baseline machine learning models.